21st September : World Alzheimer's Day. 📅
Our company actively contributes to the fight against Alzheimer's disease by developing a program with the aim of validating the clinical performance of the best non-coding RNA panel, which would allow the early diagnosis of Alzheimer's disease (AD)
As you know, Bill Gates, a longtime supporter of Alzheimer's research and initial partner of the ADDF's Diagnostics Accelerator (DxA), a global research initiative dedicated to fast-tracking the development of affordable and accessible diagnostic tools and biomarkers.
Firalis and its affiliate AMONETA Diagnostics develops new diagnostic and therapeutic tools based on non-coding RNAs thanks to the ADDF funding within the DxA initiative.
In his latest Gates Notes, Gates, who recently lost his father to Alzheimer’s disease, captures the reality for families of patients with Alzheimer’s and his optimism that this will soon be very different.